Researchers found that using benzodiazepines can significantly reduce the effectiveness of lifestyle interventions aimed at improving mobility in older adults. In a study involving over 1,500 participants with an average age of nearly 79, those who used benzodiazepines were more likely to develop mobility disabilities compared to non-users. Specifically, 55% of benzodiazepine users experienced mobility decline during the follow-up, versus 43.6% of non-users. This highlights a crucial link between medication use and the ability to maintain physical function as we age.

For those looking to age well, this research underscores the importance of being cautious with benzodiazepine use. While lifestyle interventions like exercise and nutritional counseling can help preserve mobility and prevent disability, they may not be as effective for individuals taking these medications. If you’re an older adult or care for one, understanding the potential drawbacks of benzodiazepine use could be vital in maintaining mobility, strength, and overall quality of life.

The study analyzed data from the ‘Sarcopenia and Physical frailty IN older people: multi-componenT Treatment strategies’ trial, which included a large group of older adults. It found that lifestyle interventions had a significant positive effect on mobility disability only among those not using benzodiazepines. This suggests that while lifestyle changes are beneficial, the presence of benzodiazepines can overshadow these advantages. The findings are compelling but should be viewed as part of a broader conversation about medication management in older adults.

If you or someone you know is taking benzodiazepines, consider discussing alternatives or additional support with a healthcare provider, especially if mobility and physical function are priorities for healthy aging.